MiniMed (MMED) Research & Development (2025 - 2026)
MiniMed's (MMED) quarterly Research & Development came in at $99.0 million in Q2 2026, down 7.48% YoY from $107.0 million in Q2 2025, and down 13.16% on a QoQ basis from $114.0 million in Q1 2026.
MiniMed (MMED) Research & Development (2025 - 2026) Analysis & Trends
MiniMed (MMED) has 2 years of Research & Development data on file, last reported at $99.0 million in Q2 2026.
- Quarterly Research & Development fell 7.48% year-over-year to $99.0 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $432.0 million (changed N/A YoY) and the FY2026 annual result came in at $448.0 million, up 2.75% from the prior year.
- Research & Development declined to $99.0 million in Q2 2026, from $114.0 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $114.0 million in Q1 2026 to a low of $99.0 million in Q2 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | 208.32 Mn |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | - |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | 26.83 Mn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | 56.79 Mn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | 81.41 Mn |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | 99.00 Mn |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | 50.38 Mn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | 45.05 Mn |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | 30.58 Mn |
| 10 | Privia Health | 2.78 Bn | 2.42 Bn | - | 8.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 24, 2026 | 99.00 Mn |
| Jan 23, 2026 | 114.00 Mn |
| Apr 25, 2025 | 107.00 Mn |
| Jan 24, 2025 | 112.00 Mn |